Endocan: A Novel Marker for Colchicine Resistance in Familial Mediterranean Fever Patients?
Introduction: Familial Mediterranean fever (FMF) patients had 5–10% colchicine resistance. Although FMF attacks are characterized by acute phase elevation, there are no biomarkers that can show colchicine resistance yet. The serum endocan levels may elevate in inflammatory and auto-inflammatory dise...
Guardado en:
Autores principales: | Ahmet Omma, Berkan Armaǧan, Serdar Can Güven, Sevinç Can Sandıkçı, Seda Çolak, Çiǧdem Yücel, Orhan Küçükşahin, Abdulsamet Erden |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/21502cd033e344058d6aff87599b5b24 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine
por: Dimitrios A. Vrachatis, et al.
Publicado: (2021) -
Kawasaki disease and familial mediterranean fever gene mutations, is there any link?
por: Salehzadeh F, et al.
Publicado: (2019) -
A new variety of Bacopa monnieri obtained by in vitro polyploidization
por: Salvio Escandón,Alejandro, et al.
Publicado: (2006) -
Fibrosis retroperitoneal asociada a uso crónico de ergotamina. Tratamiento con colchicina y esteroides: Caso clínico
por: Vega,Jorge, et al.
Publicado: (2011) -
Coexisting Diseases in Patients with Familial Mediterranean Fever
por: Salehzadeh F, et al.
Publicado: (2020)